TY - JOUR
T1 - POU4F3 mutation screening in Japanese hearing loss patients
T2 - Massively parallel DNA sequencing-based analysis identified novel variants associated with autosomal dominant hearing loss
AU - Kitano, Tomohiro
AU - Miyagawa, Maiko
AU - Nishio, Shin Ya
AU - Moteki, Hideaki
AU - Oda, Kiyoshi
AU - Ohyama, Kenji
AU - Miyazaki, Hiromitsu
AU - Hidaka, Hiroshi
AU - Nakamura, Ken Ichi
AU - Murata, Takaaki
AU - Matsuoka, Rina
AU - Ohta, Yoko
AU - Nishiyama, Nobuhiro
AU - Kumakawa, Kozo
AU - Furutate, Sakiko
AU - Iwasaki, Satoshi
AU - Yamada, Takechiyo
AU - Ohta, Yumi
AU - Uehara, Natsumi
AU - Noguchi, Yoshihiro
AU - Usami, Shin Ichi
N1 - Funding Information:
This study was supported by a Health and Labour Sciences Research Grant for Research on rare and intractable diseases (H26-Nanchito (Nan)-Ippan-032) from the Ministry of Health, Labour and Welfare of Japan (SU), Practical Research Project for Rare / Intractable Disease from Japan Agency for Medical Research and Development (AMED) (SU) (16ek0109114h0002), and by a Grant-in-Aid for Scientific Research (A) (15H02565) from the Ministry of Education, Science and Culture of Japan (SU).
Publisher Copyright:
© 2017 Kitano et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
PY - 2017/5
Y1 - 2017/5
N2 - A variant in a transcription factor gene, POU4F3, is responsible for autosomal dominant nonsyndromic hereditary hearing loss, DFNA15. To date, 14 variants, including a whole deletion of POU4F3, have been reported to cause HL in various ethnic groups. In the present study, genetic screening for POU4F3 variants was carried out for a large series of Japanese hearing loss (HL) patients to clarify the prevalence and clinical characteristics of DFNA15 in the Japanese population. Massively parallel DNA sequencing of 68 target candidate genes was utilized in 2,549 unrelated Japanese HL patients (probands) to identify genomic variations responsible for HL. The detailed clinical features in patients with POU4F3 variants were collected from medical charts and analyzed. Novel 12 POU4F3 likely pathogenic variants (six missense variants, three frameshift variants, and three nonsense variants) were successfully identified in 15 probands (2.5%) among 602 families exhibiting autosomal dominant HL, whereas no variants were detected in the other 1,947 probands with autosomal recessive or inheritance pattern unknown HL. To obtain the audiovestibular configuration of the patients harboring POU4F3 variants, we collected audiograms and vestibular symptoms of the probands and their affected family members. Audiovestibular phenotypes in a total of 24 individuals from the 15 families possessing variants were characterized by progressive HL, with a large variation in the onset age and severity with or without vestibular symptoms observed. Pure-tone audiograms indicated the most prevalent configuration as mid-frequency HL type followed by high-frequency HL type, with asymmetry observed in approximately 20% of affected individuals. Analysis of the relationship between age and pure-tone average suggested that individuals with truncating variants showed earlier onset and slower progression of HL than did those with non-truncating variants. The present study showed that variants in POU4F3 were a common cause of autosomal dominant HL.
AB - A variant in a transcription factor gene, POU4F3, is responsible for autosomal dominant nonsyndromic hereditary hearing loss, DFNA15. To date, 14 variants, including a whole deletion of POU4F3, have been reported to cause HL in various ethnic groups. In the present study, genetic screening for POU4F3 variants was carried out for a large series of Japanese hearing loss (HL) patients to clarify the prevalence and clinical characteristics of DFNA15 in the Japanese population. Massively parallel DNA sequencing of 68 target candidate genes was utilized in 2,549 unrelated Japanese HL patients (probands) to identify genomic variations responsible for HL. The detailed clinical features in patients with POU4F3 variants were collected from medical charts and analyzed. Novel 12 POU4F3 likely pathogenic variants (six missense variants, three frameshift variants, and three nonsense variants) were successfully identified in 15 probands (2.5%) among 602 families exhibiting autosomal dominant HL, whereas no variants were detected in the other 1,947 probands with autosomal recessive or inheritance pattern unknown HL. To obtain the audiovestibular configuration of the patients harboring POU4F3 variants, we collected audiograms and vestibular symptoms of the probands and their affected family members. Audiovestibular phenotypes in a total of 24 individuals from the 15 families possessing variants were characterized by progressive HL, with a large variation in the onset age and severity with or without vestibular symptoms observed. Pure-tone audiograms indicated the most prevalent configuration as mid-frequency HL type followed by high-frequency HL type, with asymmetry observed in approximately 20% of affected individuals. Analysis of the relationship between age and pure-tone average suggested that individuals with truncating variants showed earlier onset and slower progression of HL than did those with non-truncating variants. The present study showed that variants in POU4F3 were a common cause of autosomal dominant HL.
UR - http://www.scopus.com/inward/record.url?scp=85019866828&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85019866828&partnerID=8YFLogxK
U2 - 10.1371/journal.pone.0177636
DO - 10.1371/journal.pone.0177636
M3 - Article
C2 - 28545070
AN - SCOPUS:85019866828
VL - 12
JO - PLoS One
JF - PLoS One
SN - 1932-6203
IS - 5
M1 - e0177636
ER -